SEC Filing Form 4 Summary

This filing reports the disposition of securities by Craig A. Wheeler, a director at AMICUS THERAPEUTICS, INC. (FOLD). The transactions occurred on April 27, 2026, in connection with the company's acquisition by BioMarin Pharmaceutical Inc. The disposition included 84,631 shares of Common Stock and various stock options. The stock options were cancelled and converted into the right to receive a cash payment based on the difference between $14.50 per share and their respective exercise prices. All reported stock options were fully vested at the time of the merger. Following these transactions, Mr. Wheeler holds no shares or options, as indicated by the post-transaction shares owned being zero.